このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Implementation of a Sepsis Chart and Its Effects on Mortality Rate in Indonesian Primary Referral Hospitals

2026年9月20日 更新者:Robert Sinto、Dr Cipto Mangunkusumo General Hospital

The goal of this observational study is to evaluate the effectiveness of implementing Koran Sepsis, or sepsis chart, a paper-based order set designed to guide the implementation of the One-hour Sepsis Bundle, in improving adherence to early sepsis management and reducing 7-day mortality among adult patients with sepsis presenting to the Emergency Department. The main questions it aims to answer are:

  1. Does implementation of a sepsis chart improve adherence to the One-hour Sepsis Bundle among adult patients with sepsis?
  2. Does implementation of a sepsis chart reduce 7-day mortality among adult patients with sepsis?

Researchers will compare the period before and after implementation of Koran Sepsis to determine whether its implementation improves adherence to the One-hour Sepsis Bundle and reduces 7-day mortality.

Participants will:

  • Receive standard clinical care for sepsis, with management documented during the first hour after sepsis is suspected or diagnosed.
  • Receive care guided by sepsis chart after its implementation at the participating hospital.
  • Have clinical data collected from their medical records, including adherence to the One-hour Sepsis Bundle and time to administration of broad-spectrum antibiotics.
  • Be followed for seven days to determine their mortality outcome.

The study will include adult patients aged ≥18 years diagnosed with sepsis according to the Sepsis-3 definition who present to the Emergency Department and are admitted to one of two participating hospitals: Cipto Mangunkusumo and Fatmawati General Hospital.

調査の概要

詳細な説明

Background

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. If not recognized and treated promptly, sepsis may progress to septic shock, resulting in multiple organ failure and death. Sepsis is a serious complication of infectious diseases and remains one of the leading causes of death worldwide, particularly in low- and middle-income countries.

Globally, an estimated 48.9 million cases of sepsis occurred in 2017, with approximately 11 million sepsis-related deaths, accounting for 19.7% of all global deaths. Data from 16 Asian countries reported an intensive care unit mortality rate of 44.5% among patients with sepsis. At Dr. Cipto Mangunkusumo National Referral Hospital (RSCM), a 2017 study reported that 64% of adult patients with infection had sepsis, defined as a Sequential Organ Failure Assessment (SOFA) score >2. Another study conducted between 2016 and 2022 reported a mortality rate of 69% among patients with sepsis at RSCM, with a higher risk of mortality among patients with metabolic comorbidities. Data from the Community Services Coordinator of the Department of Internal Medicine at RSCM also showed that 10.3% of internal medicine inpatients were diagnosed with sepsis.

The One-hour Sepsis Bundle is a set of interventions recommended to be initiated within the first hour of suspected sepsis. These interventions include measurement of serum lactate, collection of blood cultures, administration of broad-spectrum antibiotics, fluid resuscitation, and hemodynamic management, with the aim of improving tissue perfusion and achieving early infection control.

Although several studies have demonstrated the effectiveness of the One-hour Sepsis Bundle in reducing mortality, its implementation at RSCM has not been systematically evaluated. Currently, there is no specific sepsis scoring system integrated into the Hospital Information System (HIS) or clinical pathway for patients with sepsis. In addition, a review by the Medical Committee indicated that the One-hour Sepsis Bundle had not been implemented in the majority of sepsis cases presenting to the Emergency Department (ED).

Previous studies have demonstrated that the use of sepsis forms and implementation of sepsis codes may reduce mortality and length of hospital stay. One approach to improving implementation is Koran Sepsis, a paper-based order set designed to guide healthcare professionals in delivering the One-hour Sepsis Bundle. This study aims to evaluate the effectiveness of Koran Sepsis implementation on short-term mortality, defined as 7-day mortality, among patients with sepsis at during the period of September 2026 - 2027

Objectives

The primary objective of this study is to evaluate the effectiveness of Koran Sepsis implementation in improving adherence to the One-hour Sepsis Bundle and reducing 7-day mortality among patients with sepsis.

Specifically, this study aims to determine the proportion of patients receiving initial sepsis management according to the One-hour Sepsis Bundle prior to Koran Sepsis implementation and to determine the proportion of healthcare professionals adhering to the One-hour Sepsis Bundle following its implementation. The study will also compare adherence to the One-hour Sepsis Bundle before and after Koran Sepsis implementation and assess differences in 7-day mortality between the two periods.

In addition, this study aims to evaluate the association between individual components of the One-hour Sepsis Bundle, including serum lactate measurement, blood culture collection, administration of broad-spectrum antibiotics, fluid administration, and vasopressor administration, and 7-day mortality among patients with sepsis.

Study Design

This study is an observational study using a pragmatic stepped-wedge cluster design. The participating hospitals will transition sequentially from the standard-of-care period to the sepsis chart implementation period. The sequence of hospital implementation will be determined according to the order in which approval are obtained.

Sample Size Calculation

Based on the estimated number of participating hospitals, the number of steps in the stepped-wedge design, and the anticipated difference in proportions, the sample size was calculated using the formula proposed by Hemming et al., resulting in a total sample size of 304 patients from 2 hospitals.

Study Procedures and Data Collection

Patients meeting the operational definition of sepsis will be recruited consecutively during the study period. Their clinical management during the initial hour of sepsis care will be documented, including the implementation of each component of the One-hour Sepsis Bundle. Patients will subsequently be followed for seven days to determine their mortality outcome.

Data will be collected using a case report form completed by clinicians or trained research personnel based on information obtained from the patients' medical records. Information regarding sepsis management will be obtained from the electronic health record and Koran Sepsis documentation. All collected data will be processed anonymously to maintain patient confidentiality.

Study Variables and Parameters

The primary outcome of this study is 7-day mortality, defined as death occurring during hospitalization within seven days following admission.

Secondary outcomes include adherence to the One-hour Sepsis Bundle and the time to administration of broad-spectrum antibiotics. We will assess adherence to the One-hour Sepsis Bundle based on documentation of the relevant interventions in the electronic health record and Koran Sepsis. The components assessed will include serum lactate measurement, blood culture collection before antibiotic administration, administration of broad-spectrum antibiotics, administration of 30 mL/kg crystalloid fluid, and vasopressor administration when fluid resuscitation is inadequate or unsuccessful. The time to administration of broad-spectrum antibiotics will be defined as the time elapsed between sepsis diagnosis and antibiotic administration.

Patient-level characteristics that will be collected include age, sex, Charlson Comorbidity Index (CCI), lactate-modified qSOFA score, SOFA score, presence of septic shock, source of infection, and identified pathogen. Age will be categorized as 18-59 years and ≥60 years. The CCI will be calculated based on the patient's documented comorbidities and subsequently categorized as high or low according to the optimal cut-off derived from receiver operating characteristic (ROC) curve analysis. The lactate-modified qSOFA score will be determined based on clinical and laboratory parameters and categorized as high or low according to the cut-off derived from ROC curve analysis.

Hospital-level characteristics will also be collected to account for potential differences between participating centers. These variables will include the total number of inpatient admissions per month, total number of ED visits per month, number of inpatient beds, and the types of pathogens commonly identified at each hospital.

The primary exposure of interest is the implementation of Koran Sepsis. The primary clinical outcome is 7-day mortality. Adherence to the One-hour Sepsis Bundle will be evaluated as an implementation-related outcome and will also be assessed in relation to mortality. Potential confounding variables will include patient-level characteristics and hospital-level factors.

Data and Statistical Analysis

Data will undergo data entry, editing, coding, processing, and cleaning. Data quality will be assessed by identifying missing values, inconsistencies, and implausible variations before statistical analysis.

Statistical analyses will be performed using STATA version 15.1. Numerical variables will be presented as mean ± standard deviation (SD) for normally distributed data or as appropriate measures of central tendency and dispersion when the data are not normally distributed. Categorical variables will be presented as frequencies and percentages.

The primary and secondary outcomes will be analyzed using multilevel regression models to account for the clustering of observations within participating hospitals. The analysis will incorporate hospital-level random effects to account for between-hospital variability and intracluster correlation. The stepped-wedge design will also be taken into consideration in the analysis by accounting for the study period and intervention status.

This approach is intended to control for differences between participating hospitals and minimize potential bias arising from correlation among patients treated within the same hospital. Multivariable analysis will additionally be performed to adjust for relevant patient-level and hospital-level covariates. The association between individual components of the One-hour Sepsis Bundle and 7-day mortality will also be assessed. Relative risks will be calculated to compare mortality between patients who received management consistent with the One-hour Sepsis Bundle and those who did not.

Benefits

This study is expected to contribute to improving the quality of sepsis care at major hospitals in Indonesia by providing evidence regarding the implementation of the One-hour Sepsis Bundle in routine clinical practice.

The study may also identify specific aspects of early sepsis management that can be optimized to reduce mortality among patients with sepsis. Furthermore, the findings are expected to provide scientific evidence regarding the effectiveness of the One-hour Sepsis Bundle and Koran Sepsis, which may support the development of an effective and efficient system for the implementation of standardized sepsis management at participating hospitals.

研究の種類

観察的

入学 (推定)

304

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

    • DKI Jakarta
      • Jakarta Pusat、DKI Jakarta、インドネシア、10430
        • 募集
        • Dr Cipto Mangunkusumo General Hospital
        • 副調査官:
          • Sharifah Shakinah, MD
        • コンタクト:
      • Jakarta Pusat、DKI Jakarta、インドネシア、10430
        • まだ募集していません
        • Fatmawati General Hospital
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

Patients above ≥18 years diagnosed with sepsis in the emergency department in Cipto Mangunkusumo and Fatmawati General Hospital.

説明

Inclusion Criteria:

  • Adult patients aged ≥18 years.
  • Patients diagnosed with sepsis according to the Sepsis-3 definition, using the lactate-modified qSOFA score as a reference.
  • Patients presenting to the Emergency Department.
  • Patients who are subsequently admitted to one of the participating hospitals: Cipto Mangunkusumo and Fatmawati General Hospital.

Exclusion Criteria:

  • Incomplete clinical or outcome data required for the study analysis.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:OTHER
  • 時間の展望:PROSPECTIVE

コホートと介入

グループ/コホート
介入・治療
Sepsis patients

All patients included in the study, diagnosed with sepsis according to the sepsis-3 criteria

Implementation of the sepsis one-hour bundle using a paper-based chart containing instructions for the recommended bundle components.

Standard sepsis management according to existing hospital practice without implementation of the study-specific sepsis one-hour bundle order set.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
All-cause mortality
時間枠:7 days

All death attributed to any reason during study follow-up

7 days

二次結果の測定

結果測定
メジャーの説明
時間枠
Time to serum lactate measurement
時間枠:Within 1 hour after sepsis diagnosis

Time to serum lactate measurement to identify adherence to the sepsis one-hour bundle, as documented using the paper-based order set containing instructions for the sepsis one-hour bundle.

Within 1 hour after sepsis diagnosis
Time to Administration of Broad-Spectrum Antibiotics
時間枠:Within 24 hours after study inclusion

Time from sepsis diagnosis to administration of broad-spectrum antibiotics, based on documentation of patient management in the electronic health record (EHR) and sepsis record.

Within 24 hours after study inclusion
Time to blood culture collection
時間枠:Within 1 hour after sepsis diagnosis

Time to blood culture collection to identify adherence to the sepsis one-hour bundle, as documented using the paper-based order set containing instructions for the sepsis one-hour bundle.

Within 1 hour after sepsis diagnosis
Time to administration of 30 mL/kg crystalloid fluid
時間枠:Within 1 hour after sepsis diagnosis

Time to fluid administration to identify adherence to the sepsis one-hour bundle, as documented using the paper-based order set containing instructions for the sepsis one-hour bundle.

Within 1 hour after sepsis diagnosis
Vasopressor administration
時間枠:Within 24 hour after sepsis diagnosis

Identify whether any vasopressor is administered as needed.

Within 24 hour after sepsis diagnosis

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年9月1日

一次修了 (推定)

2027年9月30日

研究の完了 (推定)

2027年12月31日

試験登録日

最初に提出

2026年9月20日

QC基準を満たした最初の提出物

2026年9月20日

最初の投稿 (実際)

2026年9月28日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月28日

QC基準を満たした最後の更新が送信されました

2026年9月20日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する